Search company, investor...

Campbell Neurosciences

Founded Year



Spinoff / Spinout | Alive

About Campbell Neurosciences

Campbell Neurosciences is a biotechnology company that focuses on suicide regenerative psychiatry. It offers immunotherapy for opioid addiction, treatment of major depressive disorder and suicidal ideations through stimulation of hippocampal neurogenesis utilizing plant-based approaches, and personalized immunotherapies for reduction of brain inflammation and suicide prevention. The company was founded in 2023 and is based in San Diego, California.

Headquarters Location

San Diego, California,

United States

Missing: Campbell Neurosciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Campbell Neurosciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Campbell Neurosciences News

Therapeutic Solutions International Spin-Off Res Nova Bio Leverages FDA Cleared Tumor Blood Vessel Targeting Technology to Intravenously Deliver Cancer Killing Viruses

May 22, 2023

ELK CITY, Idaho--(BUSINESS WIRE)--Therapeutic Solutions International (TSOI) announced today its Spin-Off Company, Res Nova Bio, achieved successful delivery of a cancer killing virus to breast cancer, resulting in shrinkage of the tumor without induction of side effects. The Company, which is currently manufacturing the FDA-cleared ValloVax endothelial cell vaccine, has demonstrated that intravenous administration of viral infected ValloVax cells results in direct delivery to the breast cancer

Campbell Neurosciences Frequently Asked Questions (FAQ)

  • When was Campbell Neurosciences founded?

    Campbell Neurosciences was founded in 2023.

  • Where is Campbell Neurosciences's headquarters?

    Campbell Neurosciences's headquarters is located at San Diego.

  • What is Campbell Neurosciences's latest funding round?

    Campbell Neurosciences's latest funding round is Spinoff / Spinout.

  • Who are the investors of Campbell Neurosciences?

    Investors of Campbell Neurosciences include Therapeutic Solutions International.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.